Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-09

Clinical Trial Update: Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated Victoza (liraglutide) for its effect on dietary preferences and eating habits in adults with Type 2 diabetes mellitus and overweight; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Victoza (Liraglutide)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Type 2 Diabetes, Overweight | Phase 4 | Status: TERMINATED